
posted by Brigitte
Fees : 150€ for the Members and 350€ for the non Members.
FINAL PROGRAMME
Thursday 15 March 2012 - De Montil, Affigem
Challenges and opportunities in Paediatric development.
The conference will clarify us on two main topics related to paediatric development
The first part of the afternoon session will focus on the importance of the Non-Clinical part in a paediatric development. Both the viewpoint from an assessor at the FAMHP, and an insight on how the industry copes with some specific requirements will be presented.
The second part starts with a lesson for the future by analysing the past. Five years after the implementation of the Paediatric regulation, the time has come to make an intermediate analysis. We will hear first-hand about the extensive experience of the PDCO (EMA) and have an actualised viewpoint on how the Paediatric Committee plans to continue their effort in the future. The last presentation covers various issues encountered by companies when introducing a PIP or claiming the SPC extension and proposes some possible practical ways to resolve them.
13.30 – 14.15 Non Clinical support to paediatric drug development.
Jacqueline Carleer, Safety Assessor, Research and Development, Federal Agency for Medicines and Health Products (FAMHP), Belgium, Alternate member of the Paediatric Committee (PDCO)
14.15 – 15.00 An industry approach on Juvenile toxicity testing.
Graham Bailey, ETS President, Senior Research Fellow (Reprotox) Toxicology and Pathology Drug Safety Sciences Janssen Pharmaceutica N.V.
15.00 – 15.30 Coffee
15.30 – 16.00 PDCO, where are we heading to?
Daniel Brasseur, Chair Paediatric Committee (PDCO), EMA London - FAMHP and Children's Hospital Queen Fabiola, Brussels, Belgium
16.00 – 16.45 Legal constraints and proposals to address them
Geneviève Michaux (Counsel), Covington & Burling LLP, Belgium
16.45 – 17.15 Panel discussion
A “must attend” seminar for professionals working in national, EU and International Regulatory Affairs and colleagues from Development, Clinical Research, Project Management, Legal & Patent Departments
posted by Brigitte
2 days Introduction to Regulatory Affairs
Date : 3 & 4 May 2012
Location : Federal Agency for Medicines and Healthcare Products
Speakers : FAMHP + usual external speakers
Fees : 900€ for BRAS Members and 1.100€ for non Members
Maximum 30 seats
Programme to follow.
posted by Brigitte
National Symposium 2012
Date : Thursday 18 October 2012
Location : Sheraton Rogier
Speakers : FAMHP
Fees : 575€ for BRAS Members and 765€ for non BRAS Members
Programme to follow.